Yoonji Preville

Yoonji Preville serves as a CMC Regulatory Affairs Associate Director at AstraZeneca, leading delivery of submission ready CMC modules of Biologics, including Cell Therapy Products, for global markets. Prior to this role, Yoonji worked as a Scientist at AstraZeneca’s Analytical Science-Physiochemical Development group working on characterization studies for Biologics in development. Before joining AstraZeneca, Yoonji gained valuable experience as a Scientist at Quest Diagnostics, optimizing clinical diagnostic testings, and at MilliporeSigma-BioReliance, where Yoonji worked in Analytical Science Department to develop characterization testings for Biologics. In addition to these roles, Yoonji worked as a Research Specialist at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center contributing to pivotal studies in Clinical Cancer research and served as an FDA summer research fellow. Yoonji received a dual Bachelor of Science degree in Biology and Biochemistry with a minor in Chemistry from Virginia Polytechnic Institute and State University (Virginia Tech) and holds a Master of Science degree in Pharmacology with a concentration in Neuropharmacology from Georgetown University. With a proven track record in regulatory management and scientific analysis, Yoonji remains committed to driving innovation and efficiency in the pharmaceutical industry.